Please login or register to print this page.

Clinical Articles, News & Views

CRM market on course for global boom

The global cardiac rhythm management (CRM) market is set to experience significant expansion and emerging market adoption, with revenues climbing from $10.9 billion in 2012 to more than $15.7 billion by 2020, according to a new report1 from research and consulting firm GlobalData.

The report states that the USA held the largest CRM market share in 2012, with 55%, and will continue to do so in 2020 with 45% – despite the potential slowing effect of Obamacare on revenue growth. France, Germany, Italy, Spain and the UK followed in 2012, with a share of 29%, which is due to rise to 32% by the end of the forecast period.

The anticipated expansion of the global CRM market will result from increasing incidences of arrhythmia and heart failure in the global population, combined with the growing market penetration of pacing and pulse generator technology in the Asia-Pacific and South American regions, the report says.

Rob Littlefield, GlobalData’s Senior Analyst covering Medical Devices, says: “The extremely competitive CRM market is dominated by several key players, who must continue to innovate in the face of mounting pricing pressures and strict regulation as they battle to gain market share.”

“New technologies currently under development, such as leadless pacemakers and energy harvesting generators, promise to heighten product sales and boost new account openings, while industry standards continue to develop in regards to remote home monitoring and rate-adaptive therapy,” he added.

However, the CRM market will experience some barriers to further revenue growth during the forecast period. These include the high costs surrounding new CRM devices, along with a subsequent lack of reimbursement, which is also expected to limit hospital product offerings, the report states.

“Additionally, healthcare reforms introduced by the US government in 2010, namely the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act, may adversely affect the US medical devices market by increasing pressure on device manufacturers. This could therefore slow CRM growth in what continues to be the world’s largest market shareholder,” Littlefield concludes.

References

1. Madhavan P. MediPoint: Cardiac rhythm management – global analysis and market forecasts. GlobalData 2013. Available from http://store.globaldata.com/market-reports/medical-devices/medipoint-cardiac-rhythm-management-global-analysisand-market-forecasts?utm_source=email&utm_medium=pr&utm_campaign=gdhcprq4&utm_nooveride=1

Published on: December 20, 2013

Members Area

Log in or Register now.

SEARCH THE SITE

RSS FEED

Subscribe to our RSS feed
home

GET EXCLUSIVE UPDATES

Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.

RECENT COMMENTS

    None Found

ENDORSED BY

  • ArrhythmiaAlliance
  • Stars
  • Anticoagulation Europe
  • Atrial Fibrillation Association
 

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.